These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38940301)

  • 1. Immunotherapy with γδ T-cells: the future is there.
    Kabelitz D; Yin Z
    Immunotherapy; 2024; 16(11):705-708. PubMed ID: 38940301
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential of gamma/delta T cells for solid tumor immunotherapy.
    Zhu D; Ren X; Xie W; Chen J; Liang S; Jiang M; Wang J; Zheng Z
    Front Immunol; 2024; 15():1466266. PubMed ID: 39253082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial: γδ T Cells in Cancer.
    Coffelt SB; Kabelitz D; Silva-Santos B; Kuball J; Born W; Bank I
    Front Immunol; 2020; 11():602411. PubMed ID: 33329597
    [No Abstract]   [Full Text] [Related]  

  • 4. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Empowering γδ T-cell functionality with vitamin C.
    Kabelitz D; Cierna L; Juraske C; Zarobkiewicz M; Schamel WW; Peters C
    Eur J Immunol; 2024 Jul; 54(7):e2451028. PubMed ID: 38616772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arming Vδ2 T Cells with Chimeric Antigen Receptors to Combat Cancer.
    Thomas P; Paris P; Pecqueur C
    Clin Cancer Res; 2024 Aug; 30(15):3105-3116. PubMed ID: 38747974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. γδ T cell-based anticancer immunotherapy: progress and possibilities.
    Meraviglia S; Lo Presti E; Dieli F; Stassi G
    Immunotherapy; 2015; 7(9):949-51. PubMed ID: 26569071
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-γδ TCR antibody-expanded γδ T cells: a better choice for the adoptive immunotherapy of lymphoid malignancies.
    Zhou J; Kang N; Cui L; Ba D; He W
    Cell Mol Immunol; 2012 Jan; 9(1):34-44. PubMed ID: 21666706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer immunotherapy by γδ T cells.
    Hayday A; Dechanet-Merville J; Rossjohn J; Silva-Santos B
    Science; 2024 Oct; 386(6717):eabq7248. PubMed ID: 39361750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for chimeric antigen receptor (CAR) γδ T cells: A potential game changer for adoptive T cell cancer immunotherapy.
    Mirzaei HR; Mirzaei H; Lee SY; Hadjati J; Till BG
    Cancer Lett; 2016 Oct; 380(2):413-423. PubMed ID: 27392648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research progress of gammadelta T cell-based immunotherapy].
    Qiu FM; Li ZP; Huang J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):424-9. PubMed ID: 20731045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells.
    Morandi F; Yazdanifar M; Cocco C; Bertaina A; Airoldi I
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered γδ T cells show promise in bone tumours.
    Flemming A
    Nat Rev Immunol; 2024 Jul; 24(7):458. PubMed ID: 38862639
    [No Abstract]   [Full Text] [Related]  

  • 15. Pan-cancer γδ TCR analysis uncovers clonotype diversity and prognostic potential.
    Yu X; Song L; Cen L; Cao B; Tao R; Shen Y; Abate-Daga D; Rodriguez PC; Conejo-Garcia JR; Wang X
    Cell Rep Med; 2024 Oct; 5(10):101764. PubMed ID: 39368482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bispecific T-cells expressing polyclonal repertoire of endogenous γδ T-cell receptors and introduced CD19-specific chimeric antigen receptor.
    Deniger DC; Switzer K; Mi T; Maiti S; Hurton L; Singh H; Huls H; Olivares S; Lee DA; Champlin RE; Cooper LJ
    Mol Ther; 2013 Mar; 21(3):638-47. PubMed ID: 23295945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion and Adoptive Transfer of Human Vδ2
    Sharma A; Zumwalde NA; Gumperz JE
    Methods Mol Biol; 2019; 1884():57-72. PubMed ID: 30465195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application.
    Gomes AQ; Martins DS; Silva-Santos B
    Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
    Miyashita M; Shimizu T; Ashihara E; Ukimura O
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between γδ T cells and neutrophils in cancer: knowns and unknowns.
    Hao J; Granot Z
    J Leukoc Biol; 2024 May; 115(6):993-995. PubMed ID: 38498617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.